vanadates has been researched along with Metabolic Syndrome in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Diaz, A; Flores, G; Gonzalez-Vergara, E; Guevara, J; Muñoz-Arenas, G; Treviño, S; Vázquez-Roque, R; Venegas, B | 1 |
| Hattori, M; Jakusch, T; Katoh, A; Kiss, T; Sakurai, H | 1 |
| Rosa, J; Skala, H | 1 |
| Chang, YC; Jin, UH; Kang, YJ; Kim, CH | 1 |
| Karmaker, S; Saha, TK; Sakurai, H; Yoshikawa, Y | 1 |
| Sakurai, H | 1 |
2 review(s) available for vanadates and Metabolic Syndrome
| Article | Year |
|---|---|
Metallo-allixinate complexes with anti-diabetic and anti-metabolic syndrome activities.
Topics: Diabetes Mellitus; Humans; Hypoglycemic Agents; Metabolic Syndrome; Molecular Structure; Pyrones; Vanadates | 2010 |
[Treatment of diabetes in experimental animals by metallocomplexes].
Topics: Animals; Diabetes Mellitus; Diabetes Mellitus, Experimental; Drug Design; Glucose Transporter Type 4; Humans; Hypoglycemic Agents; Metabolic Syndrome; Vanadates; Zinc Compounds | 2008 |
4 other study(ies) available for vanadates and Metabolic Syndrome
| Article | Year |
|---|---|
Metforminium Decavanadate (MetfDeca) Treatment Ameliorates Hippocampal Neurodegeneration and Recognition Memory in a Metabolic Syndrome Model.
Topics: Animals; Catalase; Drug Combinations; Hippocampus; Inflammation; Male; Memory; Metabolic Syndrome; Metformin; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Oxidative Stress; Rats, Wistar; Superoxide Dismutase; Vanadates | 2021 |
Effects of vanadate on glucose production in cultured hepatocytes isolated from rats on high saturated fat diet.
Topics: Animals; Cells, Cultured; Dietary Fats; Glucagon; Glucose; Hepatocytes; Insulin; Male; Metabolic Syndrome; Rats; Rats, Wistar; Vanadates | 2005 |
Secretion of atherogenic risk factor apolipoprotein B-100 is increased by a potential mechanism of JNK/PKC-mediated insulin resistance in liver cells.
Topics: Adaptor Proteins, Signal Transducing; Apolipoprotein B-100; Carrier Proteins; Cells, Cultured; Enzyme Inhibitors; Hepatocytes; Humans; Insulin Receptor Substrate Proteins; Insulin Resistance; JNK Mitogen-Activated Protein Kinases; Lipoproteins, VLDL; Metabolic Syndrome; Phosphorylation; Protein Kinase C; Protein Serine-Threonine Kinases; Risk Factors; Serine; Tetradecanoylphorbol Acetate; Vanadates | 2008 |
Amelioration of hyperglycemia and metabolic syndromes in type 2 diabetic KKA(y) mice by poly(gamma-glutamic acid)oxovanadium(IV) complex.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Glucose Tolerance Test; Hyperglycemia; Insulin; Leptin; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Obesity; Polyglutamic Acid; Vanadates | 2007 |